About
CryoTherapeutics SA is a medical device company focused on developing innovative cryotherapy systems for treating coronary artery disease. Their core technology features a patented intravascular catheter that delivers sub-zero temperatures directly to inflamed and high-risk atherosclerotic plaques in the coronary arteries. This treatment aims to stabilize vulnerable lesions, promoting arterial repair and reducing the risk of plaque rupture without the need for permanent stents. Founded in December 2009, CryoTherapeutics operates from Liège, Belgium, and collaborates with various partners while receiving support from public investors and private venture capital firms. The company has completed first-in-human clinical studies that demonstrate the safety and potential efficacy of its cryotherapy system, with findings presented at major cardiology conferences. Their primary customers include interventional cardiologists and healthcare providers specializing in cardiovascular disease management, targeting patients with high-risk coronary artery plaques.
Technologies
Keywords
Company Information
-
Employees 25
-
Founded 2009
-
Annual Revenue $1000000
-
Total Funding $22457716
Location
174 Rue de Bruxelles, Awans, Walloon Region, Belgium, 4340
